2024 ASCRS Continuing Medical Education
CME Mission Statement
ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates the ASCRS Refractive Day for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Physicians can claim CME credit up to the maximum listed above for attending the Physicians Program (ASCRS), including scientific films and posters on-demand, scientific papers, courses, symposia and general sessions). Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges to be eligible to claim credits and evaluate the program.
Target Audience
This educational activity has been designed for the Anterior Segment Surgeons and Comprehensive Ophthalmologists.
Educational Objectives
- Review skills needed during preoperative assessment for insightful patient selection and effective patient counseling to ensure patient satisfaction and expectations for the future.
- Examine how different diagnostics help guide preoperative decisions and patient conversations and how refractive surgery procedures have evolved.
- Explain the impact of presbyopia and compare the current options available.
- Compare and contrast all new technologies available in refractive cataract surgery.
- Demonstrate how to approach patients with varied ocular conditions to increase their understanding, expectations, and satisfaction with their refractive procedure.
- Discuss how to help manage unhappy postop refractive cataract surgery patients.
- Discuss audience response questions with panel.
Financial Interest Index
As a provider accredited by the Accreditation council for Continuing Medical Education, ASCRS must ensure balance, independence, objectivity, and scientific rigor in all its individually or jointly provided activities.
All individuals participating in an activity designated for CME credit must disclose any financial interest or relationship with an ineligible company within the past 24 months that produces, markets, sells, resells, or distributes ophthalmic products/devices/drugs or services used on or by patients that are discussed in an educational presentation or lack thereof. Financial interest can include such things as grants or research support, consultant, stockholder, member of speaker’s bureau, et.
The intent of this disclosure is not to disqualify anyone from participating, but to provide the program committee with information so they can design and implement a balanced, independent, and scientific educational activity. The Financial Interest Index provides information to attendees, so they can make their own judgement regarding the interest or relationship and the materials presented. A complete listing of relations disclosed, and their corresponding codes are below.
Session I: Swimming the Waves of Corneal Refractive and Phakic IOL Surgery
Vance Thompson, MD is a consultant for Alcon, Johnson and Johnson, Oyster Point Pharma and Staar. Receives lecture fees from Alcon, Johnson and Johnson and Oyster Point Pharma. Receives research/grant support from Alcon, Johnson and Johnson, Ocular Therapeutix and Staar. Is an equity owner/investor in Oyster Point Pharma.
Audrey Talley Rostov, MD is a consultant for Staar Surgical and receives research/grant support from Alcon.
William Wiley, MD is a consultant for Alcon, Johnson and Johnson and Staar Surgical. Receives lecture fees from Alcon. Receives research/grant support from Staar Surgical.
Eric Donnenfeld, MD has no relevant financial relationships.
Steven Dell, MD has no relevant financial relationships.
Preeya Gupta, MD is a consultant for Azura Ophthalmics, Alcon, HanAll Biopharma, Johnson and Johnson Vision, Ocular Therapeutix, Oyster Point, Sight Sciences, Surface Ophthalmics, Sun Pharma and Tear Lab. Is an equity owner/investor in Azura Ophthalmics, Oyster Point, and Surface Ophthalmics.
Julie Schallhorn, MD has no relevant financial relationships.
Karolinne Rocha, MD, PhD is a consultant for Johnson and Johnson and Zeiss.
William Wiley, MD is a consultant for and receives research/grant support from Zeiss.
Luke Rebenitsch, MD is a consultant for Staar Surgical.
Session II: RLE: What Would Roger Do?
Vance Thompson, MD has no relevant financial relationships.
Stephen Slade, MD has no relevant financial relationships.
Session III: Cycling the Range of Presbyopia Treatments
Daniel Chang, MD has no relevant financial relationships.
Lisa McIntire, MD has no relevant financial relationships.
Marguerite McDonald, MD has no relevant financial relationships.
George Waring IV, MD has no relevant financial relationships.
Kathryn Hatch, MD has no relevant financial relationships.
Marcony Santhiago, MD, PhD has no relevant financial relationships.
Roger Zaldivar, MD is a consultant for Staar Surgical and Alcon.
Gregory Parkhurst, MD, FACS has no relevant financial relationships.
Session IV: Running the Distance with Refractive Cataract Surgery
Cathleen McCabe, MD is a consultant for Alcon, Bausch and Lomb, Zeiss and Sight Sciences. Receives research/grant support from Alcon and Sun Pharmaceuticals. Receives lecture fees from Alcon, Bausch and Lomb, Sight Sciences and Ocular Therapeutix.
Kendall Donaldson, MD is a consultant for Alcon, Johnson and Johnson, Bausch and Lomb, and Zeiss.
Jennifer Loh, MD is a consultant for Alcon, Bausch and Lomb, Johnson and Johnson, Oyster Point, Sight Sciences, and Sun Ophthalmics. Receives lecture fees from Alcon, Bausch and Lomb, Sight Sciences and Sun Ophthalmics.
Nandini Venkateswaran, MD has no relevant financial relationships.
Inder Paul Singh, MD is a consultant for Alcon, Allergan, Bausch and Lomb, New World Medical, Glaukos, Sight Sciences and Belkin. Receives lecture fees from Alcon, Allergan, Bausch and Lomb, New World Medical, Glaukos, Sight Sciences and Belkin. Receives research/grant support from Alcon, Allergan, New World Medical, Glaukos and Sight Sciences.
John Hovanesian, MD has no relevant financial relationships.
Marjan Farid, MD has no relevant financial relationships.
Zaina Al-Mohtaseb, MD is a consultant for Alcon, Zeiss, Bausch and Lomb and Johnson and Johnson.
Mitchell Weikert has no relevant financial relationships.
Filomena Ribeiro, MD, PhD has no relevant financial relationships.
Session V: Finishing Strong with Audience Q&A
Vance Thompson, MD has no relevant financial relationships.
Audrey Tally Rostov, MD has no relevant financial relationships.
Daniel Chang, MD has no relevant financial relationships.
Lisa McIntire, MD has no relevant financial relationships.
Kendall Donaldson, MD has no relevant financial relationships.
Cathleen McCabe, MD has no relevant financial relationships.
Parag Parkeh, MD has no relevant financial relationships.
Roger Zaldivar, MD, MBA, MSc has no relevant financial relationships.
William Wiley, MD has no relevant financial relationships.
Carrie Braden, ASCRS Staff, have no financial interests.
All of the relevant financial relationships for these individuals have been mitigated.
